Literature DB >> 24412473

C-Src-mediated phosphorylation of δ-catenin increases its protein stability and the ability of inducing nuclear distribution of β-catenin.

Yongfeng He1, Hangun Kim2, Taeyong Ryu1, Kwang-Youl Lee1, Won-Seok Choi3, Kyeong-Man Kim1, Mei Zheng1, Yechan Joh3, Jae-Hyuk Lee4, Dong-Deuk Kwon4, Qun Lu5, Kwonseop Kim6.   

Abstract

Although δ-catenin was first considered as a brain specific protein, strong evidence of δ-catenin overexpression in various cancers, including prostate cancer, has been accumulated. Phosphorylation of δ-catenin by Akt and GSK3β has been studied in various cell lines. However, tyrosine phosphorylation of δ-catenin in prostate cancer cells remains unknown. In the current study, we demonstrated that Src kinase itself phosphorylates δ-catenin on its tyrosine residues in prostate cancer cells and further illustrated that Y1073, Y1112 and Y1176 of δ-catenin are predominant sites responsible for tyrosine phosphorylation mediated by c-Src. Apart from c-Src, other Src family kinases, including Fgr, Fyn and Lyn, can also phosphorylate δ-catenin. We also found that c-Src-mediated Tyr-phosphorylation of δ-catenin increases its stability via decreasing its affinity to GSK3β and enhances its ability of inducing nuclear distribution of β-catenin through interrupting the integrity of the E-cadherin. Taken together, these results indicate that c-Src can enhance the oncogenic function of δ-catenin in prostate cancer cells.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  E-cadherin; GSK3; Tyrosine phosphorylation; c-Src; δ-Catenin

Mesh:

Substances:

Year:  2014        PMID: 24412473      PMCID: PMC4074208          DOI: 10.1016/j.bbamcr.2013.12.021

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  42 in total

1.  Bcr-Abl stabilizes beta-catenin in chronic myeloid leukemia through its tyrosine phosphorylation.

Authors:  Addolorata Maria Luce Coluccia; Angelo Vacca; Mireia Duñach; Luca Mologni; Sara Redaelli; Victor H Bustos; Daniela Benati; Lorenzo A Pinna; Carlo Gambacorti-Passerini
Journal:  EMBO J       Date:  2007-02-22       Impact factor: 11.598

Review 2.  Nonreceptor tyrosine kinases in prostate cancer.

Authors:  Yu-Ming Chang; Hsing-Jien Kung; Christopher P Evans
Journal:  Neoplasia       Date:  2007-02       Impact factor: 5.715

3.  Cables links Robo-bound Abl kinase to N-cadherin-bound beta-catenin to mediate Slit-induced modulation of adhesion and transcription.

Authors:  Jinseol Rhee; Tim Buchan; Lawrence Zukerberg; Jack Lilien; Janne Balsamo
Journal:  Nat Cell Biol       Date:  2007-07-08       Impact factor: 28.824

4.  Specific phosphorylation of p120-catenin regulatory domain differently modulates its binding to RhoA.

Authors:  Julio Castaño; Guiomar Solanas; David Casagolda; Imma Raurell; Patricia Villagrasa; Xosé R Bustelo; Antonio García de Herreros; Mireia Duñach
Journal:  Mol Cell Biol       Date:  2006-12-28       Impact factor: 4.272

5.  Presenilin-1 D257A and D385A mutants fail to cleave Notch in their endoproteolyzed forms, but only presenilin-1 D385A mutant can restore its gamma-secretase activity with the compensatory overexpression of normal C-terminal fragment.

Authors:  Hangun Kim; Hyunkyoung Ki; Hee-Sae Park; Kwonseop Kim
Journal:  J Biol Chem       Date:  2005-03-29       Impact factor: 5.157

6.  Tyrosine residues 654 and 670 in beta-catenin are crucial in regulation of Met-beta-catenin interactions.

Authors:  Gang Zeng; Udayan Apte; Amanda Micsenyi; Aaron Bell; Satdarshan P S Monga
Journal:  Exp Cell Res       Date:  2006-08-10       Impact factor: 3.905

Review 7.  p120 catenin and phosphorylation: Mechanisms and traits of an unresolved issue.

Authors:  Stefano Alemà; Anna Maria Salvatore
Journal:  Biochim Biophys Acta       Date:  2006-06-17

8.  Increased expression of delta-catenin/neural plakophilin-related armadillo protein is associated with the down-regulation and redistribution of E-cadherin and p120ctn in human prostate cancer.

Authors:  Qun Lu; Larry J Dobbs; Christopher W Gregory; George W Lanford; Monica P Revelo; Scott Shappell; Yan-hua Chen
Journal:  Hum Pathol       Date:  2005-09-06       Impact factor: 3.466

9.  Expression and biological role of δ-catenin in human ovarian cancer.

Authors:  Yuanyuan Fang; Zhengtao Li; Xiuxia Wang; Shulan Zhang
Journal:  J Cancer Res Clin Oncol       Date:  2012-06-15       Impact factor: 4.553

10.  Presenilin-1 inhibits delta-catenin-induced cellular branching and promotes delta-catenin processing and turnover.

Authors:  Jin-Sook Kim; Sonja Bareiss; Kyung Keun Kim; Rodney Tatum; Jeong-Ran Han; Yun Hye Jin; Hangun Kim; Qun Lu; Kwonseop Kim
Journal:  Biochem Biophys Res Commun       Date:  2006-11-02       Impact factor: 3.575

View more
  5 in total

1.  Early signaling dynamics of the epidermal growth factor receptor.

Authors:  Raven J Reddy; Aaron S Gajadhar; Eric J Swenson; Daniel A Rothenberg; Timothy G Curran; Forest M White
Journal:  Proc Natl Acad Sci U S A       Date:  2016-02-29       Impact factor: 11.205

2.  δ-Catenin promotes cell migration and invasion via Bcl-2-regulated suppression of autophagy in prostate cancer cells.

Authors:  Zhiwei Chen; Hyoung Jae Lee; Hangun Kim; Sayeon Cho; Kwonseop Kim
Journal:  Am J Cancer Res       Date:  2022-01-15       Impact factor: 6.166

Review 3.  Genetic alterations of δ-catenin/NPRAP/Neurojungin (CTNND2): functional implications in complex human diseases.

Authors:  Qun Lu; Byron J Aguilar; Mingchuan Li; Yongguang Jiang; Yan-Hua Chen
Journal:  Hum Genet       Date:  2016-07-05       Impact factor: 4.132

4.  Frequently rearranged and overexpressed δ-catenin is responsible for low sensitivity of prostate cancer cells to androgen receptor and β-catenin antagonists.

Authors:  Piyan Zhang; Janet Schaefer-Klein; John C Cheville; George Vasmatzis; Irina V Kovtun
Journal:  Oncotarget       Date:  2018-05-11

5.  Interaction of EGFR to δ-catenin leads to δ-catenin phosphorylation and enhances EGFR signaling.

Authors:  Yongfeng He; Taeyong Ryu; Nensi Shrestha; Tingting Yuan; Hangun Kim; Hridaya Shrestha; Young-Chang Cho; Young-Woo Seo; Woo Keun Song; Kwonseop Kim
Journal:  Sci Rep       Date:  2016-02-17       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.